Immuron (IMRN) Net Cash Flow (2016 - 2024)
Immuron (IMRN) posted quarterly Net Cash Flow of -$2.8 million for Q4 2024, down 50.08% year-on-year from -$5.6 million in Q1 2024, and down 50.08% on a QoQ basis from -$1.9 million in Q4 2023.
Immuron (IMRN) Net Cash Flow (2016 - 2024) Analysis & Trends
Immuron (IMRN) has reported Net Cash Flow for 9 consecutive years, with -$2.8 million the latest figure, recorded in Q4 2024.
- Quarterly Net Cash Flow fell 50.08% year-over-year to -$2.8 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$2.8 million (down 50.08% YoY) and the FY2025 annual result came in at -$8.8 million, down 59.19% from the prior year.
- Net Cash Flow eased to -$2.8 million in Q4 2024 per IMRN's latest filing, from -$1.9 million in the prior quarter.
- Over the last five years, Net Cash Flow for IMRN reached as high as $23.9 million in Q4 2020 and fell as low as -$2.9 million in Q2 2021.
- A 5-year average of $1.1 million and a median of -$1.9 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2020 — Net Cash Flow surged 8005.28% — and 2023, when it slumped 65699.3%.
- Year by year, Net Cash Flow stood at $23.9 million in 2020, then plunged by 99.97% to $8209.2 in 2021, then slumped by 65.21% to $2856.0 in 2022, then sank by 65699.3% to -$1.9 million in 2023, then slumped by 50.08% to -$2.8 million in 2024.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$2.8 million, -$1.9 million, and -$1.8 million for Q4 2024, Q4 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.81 Mn |
| Dec 31, 2024 | -2.81 Mn |
| Dec 31, 2023 | -1.87 Mn |
| Dec 31, 2023 | -1.87 Mn |
| Jun 30, 2023 | -1.83 Mn |
| Jun 30, 2023 | -1.83 Mn |
| Dec 31, 2022 | 2,855.97 |
| Dec 31, 2022 | 2,855.97 |
| Jun 30, 2022 | -2.22 Mn |
| Jun 30, 2022 | -2.22 Mn |
| Dec 31, 2021 | 8,209.16 |
| Dec 31, 2021 | 8,209.16 |
| Jun 30, 2021 | -2.88 Mn |
| Jun 30, 2021 | -2.88 Mn |
| Dec 31, 2020 | 23.89 Mn |
| Dec 31, 2020 | 23.89 Mn |
| Jun 30, 2020 | -2.22 Mn |
| Jun 30, 2020 | -2.22 Mn |
| Dec 31, 2019 | -302,214.00 |
| Dec 31, 2019 | -302,214.00 |